|
|
| | FFAGLDD Basic information |
| Product Name: | FFAGLDD | | Synonyms: | FFAGLDD;L-Aspartic acid, L-phenylalanyl-L-phenylalanyl-L-alanylglycyl-L-leucyl-L-α-aspartyl- | | CAS: | 2703745-70-2 | | MF: | C37H49N7O12 | | MW: | 783.83 | | EINECS: | | | Product Categories: | | | Mol File: | 2703745-70-2.mol |  |
| | FFAGLDD Chemical Properties |
| Boiling point | 1218.664±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.332±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 2.719±0.10(predicted) |
| | FFAGLDD Usage And Synthesis |
| Uses | FFAGLDD is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release[1]. | | IC 50 | MMP9 | | References | [1] Zhou Q, et al. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine. 2018 May 18;13:2921-2942. DOI:10.2147/IJN.S158696 |
| | FFAGLDD Preparation Products And Raw materials |
|